FDA authorizes updated COVID-19 boosters for kids under 5

(SILVER SPRING, Md.) -- The U.S. Food and Drug Administration authorized bivalent COVID-19 boosters for children between the ages of 6 months and 4 years old Thursday. The booster, available from both Pfizer and Moderna, was previously authorized for everyone 5 years and older in... Read More.

FDA authorizes Novavax COVID-19 vaccine for emergency use in US

(WASHINGTON) -- Americans will likely have one more COVID-19 vaccine to choose from after the Food and Drug Administration issued an emergency use authorization for Novavax's COVID-19 vaccine Wednesday. The two-shot vaccine was authorized for use in people 18 years and older. Novavax is the fourth... Read More.

FDA authorizes 1st COVID-19 ‘breathalyzer’ test

(NEW YORK) -- The Food and Drug Administration has granted emergency use authorization for a COVID-19 test that uses breath samples -- the first of its kind to get the agency's green light. The device, called the InspectIR Covid-19 Breathalyzer, is "about the size of... Read More.

FDA authorizes Pfizer boosters for 12- to 15-year olds

(WASHINGTON) -- The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds. The moves comes as schools reopen after the holiday break. In a release, the FDA said it has amended the emergency use authorization for the Pfizer vaccine to also shorten... Read More.

FDA authorizes Merck pill for COVID-19 treatment

The Food and Drug Administration on Thursday authorized Merck's COVID-19 pill for certain adults. The authorization is limited to adults who have a high risk of severe illness and for whom alternative FDA-authorized treatment options are not accessible or medically appropriate. This is the second COVID-19... Read More.